STX1 — Syntaxin-1

Syntaxin-1 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">STX1 — Syntaxin-1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SYNTAXIN-1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>STX1 — Syntaxin-1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=SYNTAXIN-1" target="_blank">Search UniProt</a></td>
</tr>
</table>

Overview

Syntaxin-1 is a presynaptic plasma-membrane SNARE protein essential for fast calcium-triggered neurotransmitter release. It exists primarily as two closely related isoforms, syntaxin-1A and syntaxin-1B, encoded by [STX1A](/proteins/stx1a-protein) and [STX1B](/proteins/stx1b-protein). Together with [SNAP-25](/proteins/snap-25) and [Synaptobrevin-2](/proteins/synaptobrevin-2), syntaxin-1 forms the core ternary SNARE complex that drives synaptic vesicle fusion.

Brain Atlas Resources

The [Allen Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=STX1) provides gene expression data for STX1:

• Human Brain Expression: Searchable expression data across brain regions
• Cell Type Specificity: Expression patterns in different neuronal populations
• [View Expression Data](https://human.brain-map.org/microarray/search/show?search_term=STX1)

...

Syntaxin-1 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">STX1 — Syntaxin-1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SYNTAXIN-1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>STX1 — Syntaxin-1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=SYNTAXIN-1" target="_blank">Search UniProt</a></td>
</tr>
</table>

Overview

Syntaxin-1 is a presynaptic plasma-membrane SNARE protein essential for fast calcium-triggered neurotransmitter release. It exists primarily as two closely related isoforms, syntaxin-1A and syntaxin-1B, encoded by [STX1A](/proteins/stx1a-protein) and [STX1B](/proteins/stx1b-protein). Together with [SNAP-25](/proteins/snap-25) and [Synaptobrevin-2](/proteins/synaptobrevin-2), syntaxin-1 forms the core ternary SNARE complex that drives synaptic vesicle fusion.

Brain Atlas Resources

The [Allen Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=STX1) provides gene expression data for STX1:

• Human Brain Expression: Searchable expression data across brain regions
• Cell Type Specificity: Expression patterns in different neuronal populations
• [View Expression Data](https://human.brain-map.org/microarray/search/show?search_term=STX1)

Because synaptic failure is one of the earliest and most consistent events in neurodegenerative disease, [Syntaxin-1](/proteins/syntaxin-1) is a high-priority mechanistic node linking molecular exocytosis machinery to systems-level cognitive and motor decline.[@selkoe2002][@dekosky1990]

Structure and Biophysical Function

Syntaxin-1 has an N-terminal regulatory domain (including an Habc bundle), a SNARE motif, and a C-terminal transmembrane region anchoring it to the presynaptic membrane.[@jahn2012][@burkhardt2008] In resting states, syntaxin-1 can adopt a closed conformation stabilized by Munc18 proteins; during vesicle priming, conformational opening allows SNARE zippering with SNAP-25 and VAMP2.[@jahn2012][@burkhardt2008]

Core mechanistic steps:

Docking/priming interface via Munc18-1 and Munc13 pathway coordination.[@jahn2012][@ma2013]

SNARE complex assembly with SNAP-25 and VAMP2, creating a metastable fusion machine.[@sdhof2009][@rizo2015]

Calcium-triggered fusion through coupling to [Synaptotagmin-1](/proteins/synaptotagmin-1), yielding rapid transmitter release.[@rizo2015][@chapman2008]

Post-fusion recycling coordinated with NSF/SNAP-mediated disassembly and vesicle endocytic recovery.[@sdhof2009][@ma2013]

Disruption at any of these stages can reduce synaptic reliability, alter network oscillations, and increase vulnerability to neurodegenerative circuit collapse.

Role in Neurodegeneration-Relevant Mechanisms

Synaptic Vulnerability in AD and Tauopathies

Synapse loss strongly predicts cognitive decline in [Alzheimer's disease](/diseases/alzheimers-disease).[@selkoe2002] Proteomic and pathological studies report presynaptic marker disruption, including SNARE machinery abnormalities, in vulnerable cortical and hippocampal regions.[@dekosky1990][@bereczki2014] Reduced effective syntaxin-1 function is expected to worsen information transfer efficiency and accelerate memory-network failure.

Interaction with Alpha-Synuclein Biology in PD

[Alpha-synuclein](/proteins/alpha-synuclein) directly interacts with SNARE components and can modulate assembly/disassembly dynamics.[@burr2010] In [Parkinson's disease](/diseases/parkinsons-disease), abnormal alpha-synuclein states may perturb SNARE-dependent exocytosis, contributing to dopaminergic terminal dysfunction before overt neuronal death.[@burr2010][@choi2013]

Excitability and Epileptiform Risk

Pathogenic variation in STX1B is linked to developmental epileptic encephalopathy and febrile-seizure phenotypes, underscoring how syntaxin-1 dosage/function shapes network excitability margins.[@schubert2014][@wolking2019] This excitability axis is relevant to neurodegeneration contexts where inhibitory/excitatory imbalance emerges secondarily.

Proteostasis and Presynaptic Stress

SNARE proteins undergo tight turnover and quality-control regulation. When proteostasis is strained, presynaptic release probability can collapse, reinforcing the broad [synaptic dysfunction](/mechanisms/synaptic-dysfunction) cascade observed across AD, PD, ALS-FTD spectrum disorders.[@selkoe2002][@dekosky1990][@choi2013]

Clinical and Translational Relevance

Biomarker Framing

Syntaxin-1 is primarily a mechanistic and target-engagement marker rather than a standalone diagnostic biomarker. Useful translational roles include:

• Presynaptic panel integration with SNAP-25 and synaptotagmin readouts in CSF/plasma research settings.[@bereczki2014][@brinkmalm2014]
• Correlative use with EEG or network-level physiological metrics to interpret synaptic function restoration efforts.
• Stratification of synaptic-targeted interventions in early-stage neurodegeneration trials.

Therapeutic Implications

Direct syntaxin-1 agonism is not currently a clinical strategy, but several intervention classes converge on syntaxin-1-dependent biology:

Synaptic vesicle cycle modulators that improve release fidelity or vesicle turnover.

Alpha-synuclein-directed therapies that may indirectly normalize SNARE interface stress.[@burr2010][@choi2013]

Activity-dependent plasticity programs (pharmacologic and rehabilitation) that require preserved presynaptic release machinery to achieve durable effects.

In practice, syntaxin-1 is best treated as a pathway hub: preserving SNARE-cycle integrity may magnify downstream benefit from broader disease-modifying strategies.

Research Priorities

Priority next steps for [Syntaxin-1](/proteins/syntaxin-1) in neurodegeneration research:

• Isoform-specific mapping of STX1A versus STX1B vulnerability across disease stages.
• Longitudinal linkage between SNARE proteomics and cognitive/motor trajectories.
• Mechanistic studies of alpha-synuclein conformer effects on SNARE kinetics in human neuronal systems.
• Combination-trial frameworks that integrate synaptic-target engagement with anti-proteinopathy therapies.

Pathway & Interaction Diagram

Interactive diagram showing SYNTAXIN-1's key relationships in the SciDEX knowledge graph (6 connections shown).

See Also

• [STX1A](/proteins/stx1a-protein)
• [STX1B](/proteins/stx1b-protein)
• [SNAP-25](/proteins/snap-25)
• [Synaptobrevin-2](/proteins/synaptobrevin-2)
• [Synaptic Dysfunction](/mechanisms/synaptic-dysfunction)

External Links

• [UniProt: syntaxin-1](https://www.uniprot.org/)
• [PubMed: syntaxin-1](https://pubmed.ncbi.nlm.nih.gov/?term=syntaxin-1+neurodegeneration)

References

[Südhof TC, Rothman JE, Membrane fusion: grappling with SNARE and SM proteins (2009)](https://pubmed.ncbi.nlm.nih.gov/23354322/)

[Jahn R, Fasshauer D, Molecular machines governing exocytosis of synaptic vesicles (2012)](https://pubmed.ncbi.nlm.nih.gov/24003658/)

[Rizo J, Xu J, The synaptic vesicle release machinery (2015)](https://pubmed.ncbi.nlm.nih.gov/25310905/)

[Selkoe DJ, Alzheimer's disease is a synaptic failure (2002)](https://pubmed.ncbi.nlm.nih.gov/19225279/)

[DeKosky ST, Scheff SW, Synapse loss in frontal cortex biopsies in Alzheimer's disease (1990)](https://pubmed.ncbi.nlm.nih.gov/3399300/)

[Burkhardt P, Hattendorf DA, Weis WI, Fasshauer D, Munc18a controls SNARE assembly through its interaction with syntaxin (2008)](https://pubmed.ncbi.nlm.nih.gov/18032617/)

[Ma C, Su L, Seven AB, Xu Y, Rizo J, Reconstitution of the vital functions of Munc18 and Munc13 in neurotransmitter release (2013)](https://pubmed.ncbi.nlm.nih.gov/25122680/)

[Chapman ER, How does synaptotagmin trigger neurotransmitter release? (2008)](https://pubmed.ncbi.nlm.nih.gov/15961159/)

[Bereczki E, Branca RM, Francis PT, et al, Synaptic markers of cognitive decline in neurodegeneration (2014)](https://pubmed.ncbi.nlm.nih.gov/25009163/)

[Burré J, Sharma M, Tsetsenis T, et al, Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro (2010)](https://pubmed.ncbi.nlm.nih.gov/23913201/)

[Choi BK, Choi MG, Kim JY, et al, Large alpha-synuclein oligomers inhibit SNARE-mediated vesicle docking (2013)](https://pubmed.ncbi.nlm.nih.gov/21709235/)

[Schubert J, Siekierska A, Langlois M, et al, Mutations in STX1B cause fever-associated epilepsy syndromes (2014)](https://pubmed.ncbi.nlm.nih.gov/27453579/)

[Wolking S, May P, Mei D, et al, Clinical spectrum of STX1B-related epileptic disorders (2019)](https://pubmed.ncbi.nlm.nih.gov/30061314/)

[Brinkmalm A, Brinkmalm G, Honer WG, et al, SNAP-25 as a synaptic biomarker in cerebrospinal fluid (2014)](https://pubmed.ncbi.nlm.nih.gov/24477983/)